ENHANCED CYTOTOXICITY OF MULTIPLE MYELOMA CELLS USING DARATUMUMAB IN COMBINATION WITH NK CELLS ENGINEERED TO EXPRESS HIGH-AFFINITY CD16 (F158V)

Michael O'Dwyer

Research output: Other contribution (Published) › Other contribution

Original languageEnglish (Ireland)
Media of outputOther Item
Volume103
Publication statusPublished - 1 Apr 2018

Cite this